Sanofi Ends Drug Program After Late-Stage Trial in Lung Cancer Fails

By Adria Calatayud Sanofi said it would end a clinical-development program for its tusamitamab ravtansine drug candidate after a late-stage trial in...

Related Keywords

France ,French ,Adria Calatayud , ,Article Normal ,Pharmaceuticals ,Healthcare Life Sciences ,New Products Services ,Research Development ,Corporate Industrial News ,Products Services ,New Product Service Testing ,Cancer ,Political General News ,Respiratory Tract Diseases ,Health ,Respiratory Tract Cancer ,Medical Conditions ,Content Types ,Factiva Filters ,C Amp Ampe Industry News Filter ,Synd ,Sanofi ,San Fr ,Fr San ,Us80105n1054 ,Fr0000120578 ,Sny ,New Products ,Services ,Research ,Development ,Corporate ,Industrial News ,Products ,New Product ,Service Testing ,Political ,General News ,Healthcare ,Life Sciences ,